Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 17  •  04:00PM ET
37.08
Dollar change
+0.55
Percentage change
1.50
%
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsGlobal Return% 1Y46.46% Total Holdings56 Perf Week1.42%
SponsorTema ETF Type Tagsequity Return% 3Y- AUM150.81M Perf Month1.20%
Fund Family Bond Type Tagshealthcare Return% 5Y- NAV/sh Perf Quarter13.02%
Index- Average Maturity Tags- Return% 10Y 52W High37.51 -1.15% Perf Half Y38.85%
Index Weighting Commodity Type Tags- Return% SI 52W Low20.10 84.52% Perf YTD6.80%
Active/Passive Quant Type Tags- Flows% 1M9.80% Volatility1.83% 1.86% Perf Year47.08%
Dividend TTM0.02 (0.05%) ESG Type Tags- Flows% 3M45.70% ATR (14)0.72 Perf 3Y-
Dividend Ex-DateDec 10, 2025 Dividend Type Sector/Theme Flows% YTD24.03% RSI (14)58.98 Perf 5Y-
Dividend Gr. 3/5Y- - Structure Type Region Flows% 1Y Beta0.94 Perf 10Y-
Expense0.75% Growth/Value SMA201.57% Flows% 3Y Rel Volume0.61 Prev Close36.53
Inverse/Leveraged Market Cap SMA503.73% Flows% 5Y Avg Volume38.56K Price37.08
IPOAug 16, 2023 Option/ShortNo / Yes SMA20025.39% Trades Volume23,343 Change1.50%
Tema Oncology ETF seeks to provide long-term growth. Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.